Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo therapy aims to heal Radiation-Damaged jaw bones

NCT ID NCT06055257

First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 32 times

Summary

Radiation for head and neck cancer can sometimes cause a painful condition where the jaw bone dies (osteoradionecrosis). This pilot study tests whether adding a special drug cocktail (mPENTOCLO) to standard hyperbaric oxygen therapy works better than oxygen alone. The study will enroll 24 people and focus on whether the treatment plan is practical and if it reduces pain and the need for surgery.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEORADIONECROSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Sunnybrook Health Sciences Centre

    RECRUITING

    Toronto, Ontario, M4N3M5, Canada

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

mPENTOCLO (pentoxifylline, tocopherol, and clodronate) plus hyperbaric oxygen therapy

What this could lead to

If successful, this combination could offer a more effective, non-surgical treatment for radiation-induced jaw bone damage, reducing pain and the need for surgery.

What could go wrong

This is a very small pilot study (24 people) focused on feasibility, not proof of effectiveness. The drug regimen is complex and long (12 months), and hyperbaric oxygen requires many clinic visits.

Conditions

The condition(s) this trial relates to.

Head and Neck Neoplasms osteoradionecrosis osteoradionecrosis of the mandible

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.